Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANNABIDIOL vs CAPLACIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANNABIDIOL vs CAPLACIZUMAB: Safety Overview

Metric CANNABIDIOL CAPLACIZUMAB
Total FAERS Reports 18,243 145
Deaths Reported 1,563 34
Death Rate 8.6% 23.4%
Hospitalizations 5,149 53
Average Patient Age 21.6 yrs 53.0 yrs
% Female Patients 45.2% 51.2%
FDA Approval Date Sep 28, 2018 N/A
Manufacturer Jazz Pharmaceuticals, Inc. Genzyme Corporation
Route ORAL N/A
Marketing Status Prescription N/A